The UCP3 gene encodes a protein called ‘uncoupling protein 3’. In the mitochondria (the main powerhouse of cells), the breakdown of nutrient fuels is coupled to the production of the energy molecule ATP. Members of the uncoupling protein family prevent the production of this molecule and instead cause the energy to be dissipated as heat [R, R].
UCP3 is mainly found in muscles, but also present in smaller amounts in heart and brown fat tissues. Fasting and acute exercise increase the expression of the UCP3 gene, while endurance training reduces or increases it depending on the study [R, R, R, R, R, R, R].
The biological function of UCP3 remains poorly understood. Although it can block ATP generation to produce heat, just as its sister protein UCP1, research suggests its main role is to break down fatty acids and remove them from the inner side of the mitochondria. This may reduce oxidative damage and preserve mitochondrial function [R, R, R, R].
The UCP3 gene encodes a mitochondrial protein mainly found in the muscles and involved in energy expenditure and fatty acid breakdown.
UCP3 in Weight Control and Insulin Resistance
Engineered mice producing high UCP3 amounts had increased appetite, were protected from diet-induced obesity, and showed higher spontaneous physical activity and fatty acid breakdown in the muscles [R, R, R, R].
Surprisingly, mice lacking UCP3 showed neither obesity nor a reduced energy expenditure rate. Some scientists argued that the housing conditions at high temperature might have caused temperature stress and masked the effects of the protein [R, R, R].
Interestingly, UCP3 is also produced in the pancreatic cells that produce insulin. A study found that prediabetic and diabetic individuals had lower UCP3 levels in their muscles, which were increased after treatment with the antidiabetic drugs rosiglitazone and metformin [R, R, R, R].
Mice overproducing UCP3 had lower fasting glucose and insulin levels, increased blood sugar clearance, and enhanced insulin tolerance despite being fed high-fat diets. Studies in mice lacking UCP3 often showed reduced insulin sensitivity, but the results were mixed and dependent on the age of the mice [R, R, R, R, R].
Research in mice suggests that higher UCP3 activity protects from diet-induced obesity and insulin resistance.
Rs1800849
The most widely-investigated UCP3 polymorphism by far is rs1800849, also known as -55C/T.
Weight
The major allele ‘G’ was associated with obesity in Mexicans, and with abdominal obesity in Malaysians [R, R].
In two Spanish studies, the minor allele protected from obesity but only among those physically active or when inherited together with some UPC2 variants. In a Japanese study, carriers of this variant had lower BMI and higher HDL–cholesterol levels. This variant also protected from obesity in American and British Caucasians [R, R, R, R, R].
In diabetics, the ‘G’ allele conferred increased BMI especially if combined with a variant of the PPARγ2 gene. The ‘A’ allele was associated with lower BMI but the difference was reduced in people eating high-calorie diets. Conversely, another study in diabetics associated this allele with higher BMI and waist circumference [R, R, R].
However, multiple studies from Denmark, the US, Canada, Malaysia, Japan, Turkey, and Germany failed to associate this polymorphism with obesity [R, R, R, R, R, R, R, R, R].
Surprisingly, the minor variant was associated with increased BMI in two studies on obese Spanish and French populations [R, R].
The results of meta-analyses are similarly controversial: one found no association between this polymorphism and obesity in Asian and European descendants, another one found it protective in Europeans, and a third one associated it with a slightly increased BMI in Asians [R, R, R].
All in all, some studies suggest that the minor variant at this polymorphism may protect from obesity, especially in Caucasians. The mixed results observed may be due to differences in the diet, physical activity, and genetic background of the different populations. Importantly, different UPC2 and UPC3 variants are inherited together and their combinations may influence their effects on weight [R].
Some studies suggest that the minor UCP3 variant may protect from obesity. The results are mixed, possibly due to differences in the diet, physical activity, and genetic background of the different populations.
Fat Distribution
The less common ‘A’ variant has been associated with a higher waist circumference, resulting in a higher waist to hip ratio, in studies on populations from Germany, Spain, Great Britain, and South India. Similarly, this variant was associated with higher abdominal fat in Mexicans [R, R, R, R].
However, a Spanish study found no relationship between this polymorphism and fat mass or distribution in obese. Another study on American women associated it with increased lean mass and calorie intake [R, R].
The minor variant has also been associated with higher blood cholesterol levels (total, LDL, and HDL) [R, R, R].
Studies often associated the minor variant of this SNP with increased waist circumference and higher blood fat levels.
Diabetes
The ‘A’ allele has been associated with prediabetes in a rural Chinese population and with type 2 diabetes in British men [R, R].
However, it had no relationship with type 2 diabetes in a Danish study and even reduced the risk of developing this condition in French and Asian Indian populations. In line with this, the ‘G’ variant was the one associeted with type 2 diabetes in obese Brazilian women and a Colombian population [R, R, R, R, R].
Two meta-analyses confirmed the association of the ‘A’ variant with increased susceptibility to type 2 diabetes in Asians but not in Europeans [R, R].
The minor UCP3 variant has been associated with type 2 diabetes in Asians. However, this variant seems protective in Europeans and South Americans.
How It Works
The rs1800849 polymorphism is located in the gene region that controls UCP3 expression (the promoter) [R].
A study in Pima Indians found that the minor allele ‘A’ increases UCP3 expression, and possibly the levels of the protein, in the muscles [R].
This variant has been associated with higher resting energy expenditure in Chinese people and African American women [R, R].
The minor variant increases UCP3 expression and has been associated with increased resting energy expenditure. Higher UCP3 may help with weight loss.
Other Variants
The minor variants at the rs647126 and rs2075577 polymorphisms were associated with increased BMI in Dutch men. Based on their effect, the authors of the study speculated that these variants may reduce UCP3 activity [R].
The rs2075577 polymorphism was also associated with increased HDL-cholesterol levels in Koreans [R].
The minor variants of two less widely-investigated polymorphisms have been associated with increased BMI.
Diet
High-Protein, Low-Carbohydrate Diets
In a Spanish study, weight loss and blood insulin and leptin levels were similar after either a low-fat or a low-carbohydrate diet in obese carriers of both rs1800849 variants [R].
However, three more recent studies by the same group found that obese carriers of the ‘G’ allele experienced a higher reduction in weight, fat mass, waist circumference, and blood fats after adopting a high-protein/low-carbohydrate diet, a conventional low-calorie diet, or a low-calorie diet rich in monounsaturated fatty acids [R, R, R].
Eating a high-fat diet is associated with lower UPC3 expression in the muscles of rats, suggesting that dietary fats may suppress the beneficial effect of the ‘A’ variant on obesity prevention [R].
Some research suggests that getting more calories from proteins (as opposed to either carbohydrates or fat) may support weight loss, metabolism, and satiety. High-protein diets appeared to increase fat burning and weight loss and reduce appetite in a handful of human studies [R, R, R].
In a clinical trial on 119 overweight people, a low-carbohydrate ketogenic diet was as effective as a low-fat diet for weight loss but had the advantages that it reduced appetite and negative affect. A meta-analysis of 13 studies and over 1,500 people concluded that low-carbohydrate ketogenic diets are more effective than low-fat diets for losing weight [R, R].
Fish & Seafood
In mice and rats, dietary fish oil increased UCP3 expression in the muscles and reduced obesity and insulin resistance [R, R, R, R, R].
Fish is hypothesized to reduce leptin; higher leptin is associated with obesity. In young, overweight men, the inclusion of either lean or fatty fish or fish oil as part of an energy-restricted diet resulted in approximately 1 kg more weight loss after 4 weeks compared to a similar diet without seafood or a supplement [R, R].
Fish oil’s anti-inflammatory effects have the ability to indirectly aid in fat metabolism in people with high inflammation or metabolic syndrome. It can increase the secretion of adiponectin, which is responsible for breaking down fats [R, R].
In a large meta-analysis of 21 clinical trials, fish oil in combination with lifestyle changes significantly reduced waist-to-hip ratio although it failed to improve weight loss [R].
Intermittent Fasting
In a small trial on 14 people, eating a very low-calorie diet for 5 days caused a ~2-fold increased expression of UCP3 [R].
In mice and rats, repeated cycles of fasting and refeeding increased UCP3 expression in the muscles and prevented high-fat-induced obesity [R, R].
Intermittent fasting describes any diet in which a person eats their required caloric intake during predetermined periods of time and fasts during the remaining time. Some people choose to eat only during specific times of day (for example, between 10 AM and 6 PM), while others choose to fast for one or two entire days per week.
Fasting every other day for 12 weeks caused 32 people to lose an average of 12 pounds more than those who followed a daily program of calorie restriction. These people ate 25% of their calories every other day [R].
In a clinical trial on 52 women, caloric intake after 8:00 PM increased the risk of obesity, independent of sleep timing and duration [R].
Time-restricted feeding, a strategy in which a person only eats during a specific window of time each day, has also produced good results for weight loss. However, time-restricted feeding was not as effective as other forms of intermittent fasting, according to a meta-analysis of the practice [R, R, R].
Dark Chocolate
Cocoa enhanced energy expenditure and increased UCP3 levels in mice and rats [R, R, R].
Cocoa contains polyphenols that are believed to promote weight gain, though clinical studies are few and far between. In one study, daily consumption of 49 grams of dark chocolate reduced snacking, suggesting that cocoa might decrease appetite or cravings [R].
In a study in rats, those fed cocoa had less fat production in the belly. In mice, cocoa consumption reduced weight gain and fat uptake in the gut. Cocoa also reduced inflammation associated with obesity and improved insulin resistance [R, R].
Eating a diet high in proteins and low in fats and carbohydrates, practicing intermittent fasting, and including more fish and dark chocolate in the diet may help lose weight and increase UCP3 activity.
Supplements
Green Tea
In a small trial on 11 obese women, supplementation with EGCG increased the expression of UCP3 and other genes involved in energy and fat metabolism. However, it didn’t promote weight loss [R].
In mice, EGCG had similar effects on UCP3 expression and reduced dietary fat uptake, likely helping prevent weight gain [R].
Green tea’s active compound epigallocatechin gallate (EGCG) caused between 0.2 and 3.5 kg of weight loss in limited human studies. Green tea, meanwhile, is hypothesized to make us burn more calories, even at rest. In most studies, this amounts to a modest 3-4% increase in energy, though some studies have shown an increase as high as 8%. For a 2,000 calorie diet, 3-4% amounts to an additional 60-80 calories per day [R, R, R, R].
In one study of 60 obese individuals, the group taking green tea extract lost 7.3lbs and burned 183 more calories per day (on average) after 3 months [R, R].
Calcium
In mice fed high-fat diets, calcium supplementation increased UCP3 levels and prevented weight gain [R, R, R].
A clinical trial of 53 people found that calcium (600 mg/day) and vitamin D (125 IU/day) enhanced weight loss when combined with a restricted diet [R].
In another study of 32 obese adults, increased dietary calcium promoted weight loss and fat loss, primarily in the abdomen. Participants who ate a low-calcium diet experienced about 19% of their fat loss from the abdominal region, while those who ate a high-calcium diet experienced about 50% [R].
However, a recent review of 41 studies concluded that calcium supplements don’t increase total weight loss [R].
Conjugated Linoleic Acids
In mice and hamsters, dietary CLA increased UCP3 levels in the muscles [R, R, R].
Conjugated linoleic acids (CLA) are poly-unsaturated fatty acids. Studies have shown that CLAs decrease lipid storage by increasing the rate of fat breakdown in fat tissue [R].
A clinical trial on overweight Chinese subjects found that CLA supplementation over a 12-week period reduced body weight, BMI, total fat mass, fat percentage, waist to hip ratio, and subcutaneous fat mass [R].
It should be noted, though, that CLA supplementation did not prevent weight or fat regain after initial weight loss in a similar study in obese people [R, R].
Resveratrol
Both resveratrol and a compound combining four molecules of this polyphenol (vaticanol C) increased UCP3 expression in the muscles of obese mice and rats [R, R].
In mice fed a high-fat diet, resveratrol reduced oxidative stress and prevented the death of protective immune cells called Tregs [R].
Resveratrol stopped fat cells from making new fats and triggered their death, in cell-based studies. It accomplishes this by turning off genes that cause weight gain (such as PPAR gamma) and blocking fat-creating enzymes (fatty acid synthase, lipoprotein lipase, and hormone-sensitive lipase) while activating genes that enhance energy use and mitochondrial health (SIRT3, UCP1) [R, R].
Supplementing with EGCG, calcium, CLA, and resveratrol may help lose weight, in part by increasing UCP3 levels.